Serial interval distribution of SARS-CoV-2 infection in Brazil

…, VB Porto, D da Silva Candido, F Ghilardi… - Journal of travel …, 2021 - academic.oup.com
The novel severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) emerged in
China in December 2019 1 and was declared a pandemic by the World Health Organization …

[HTML][HTML] Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil

…, PS Andrade, VH Nascimento, F Ghilardi… - Nature human …, 2020 - nature.com
The first case of COVID-19 was detected in Brazil on 25 February 2020. We report and
contextualize epidemiological, demographic and clinical findings for COVID-19 cases during the …

[HTML][HTML] SARS-CoV-2 detection and culture in different biological specimens from immunocompetent and immunosuppressed COVID-19 patients infected with two …

MC Mendes-Correa, MC Salomão, F Ghilardi… - Viruses, 2023 - mdpi.com
Introduction—The dynamics of SARS-CoV-2 shedding and replication in humans remain
incompletely understood. Methods—We analyzed SARS-CoV-2 shedding from multiple sites in …

Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19

LC Lazari, FDR Ghilardi… - Life Science …, 2021 - life-science-alliance.org
SARS-CoV-2 infection poses a global health crisis. In parallel with the ongoing world effort
to identify therapeutic solutions, there is a critical need for improvement in the prognosis of …

[HTML][HTML] Serological screening for Chagas disease in an endemic region of Northern Minas Gerais, Brazil: the SaMi-Trop project

…, LC Oliveira, EC Sabino, FR Ghilardi… - Revista do Instituto de …, 2021 - SciELO Brasil
Chagas disease (CD) is still a neglected disease. Infected individuals are diagnosed late,
being treated in worse clinical conditions. Thus, this study aimed to analyze the prevalence …

[HTML][HTML] Parasitemia and antibody response to benznidazole treatment in a cohort of patients with chronic Chagas disease

…, JÂL Lindoso, LAM Franco, F Ghilardi… - Frontiers in …, 2023 - frontiersin.org
Background Evaluating the effectiveness of Chagas disease treatment poses challenges
due to the lack of biomarkers for disease progression and therapeutic response. In this study, …

SARS-CoV-2 shedding, infectivity and evolution in an immunocompromised adult patient

MC Mendes-Correa, F Ghilardi, MC Salomão… - medRxiv, 2021 - medrxiv.org
This report describes a persistent SARS-CoV-2 infection of at least 218 days in a male, in
his 40’s who had undergone a prior autologous hematopoietic stem cell transplant due to a …

[HTML][HTML] COVID LONGA: ESTUDO MULTICÊNTRICO BRASILEIRO

…, RM Galliez, F Leal, E Manuli, F Ghilardi… - The Brazilian Journal of …, 2023 - Elsevier
Introdução a infecção pelo SARS-CoV-2 pode levar a persistência ou desenvolvimentos de
sintomas além da fase aguda da doença, conhecida como COVID longa. Estima-se que 10-…

Epidemiological and clinical characteristics of the early phase of the COVID-19 epidemic in Brazil (preprint)

…, CA Prete Jr, VH Nascimento, F Ghilardi… - 2020 - pesquisa.bvsalud.org
BackgroundThe first case of COVID-19 was detected in Brazil on February 25, 2020. We
report the epidemiological, demographic, and clinical findings for confirmed COVID-19 cases …

[HTML][HTML] Machine learning for predicting Chagas disease infection in rural areas of Brazil

F De Rose Ghilardi, G Silva, TM Vieira… - PLOS Neglected …, 2024 - journals.plos.org
Introduction Chagas disease is a severe parasitic illness that is prevalent in Latin America
and often goes unaddressed. Early detection and treatment are critical in preventing the …